• Pharmacokinetic Variability of CSBTA in MASH: Transporter an

  2026-05-26

  This study systematically investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a mouse model. The findings reveal that pathological liver states significantly affect drug exposure and distribution by modulating key metabolizing enzymes and transporters, offering valuable guidance for optimizing clinical dosing strategies in chronic liver disease.

• Cy3 NHS ester (non-sulfonated): Technical Guide for Fluoresc

  2026-05-26

  Cy3 NHS ester (non-sulfonated) enables robust fluorescent labeling of amino groups in proteins, peptides, and oligonucleotides, particularly where organic co-solvents are acceptable. It is not suitable for workflows demanding water solubility or for delicate proteins that are sensitive to organic solvents. This article provides actionable parameters and troubleshooting strategies for maximizing labeling efficiency.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-05-25

  This study provides a comprehensive characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China. The findings reveal high prevalence, multidrug resistance, and efficient horizontal transfer of CEGs, particularly blaNDM-1, emphasizing urgent challenges for infection control and antibiotic research.

• Caspase-8: Precision Tools for Translational Cell Death Rese

  2026-05-25

  This article explores how advanced detection of caspase-8 activity, enabled by the Caspase-8 Fluorometric Assay Kit, is transforming translational research in apoptosis, pyroptosis, and neurodegenerative disease. Integrating mechanistic insights from recent oncology studies, it provides strategic guidance for researchers seeking robust, quantitative approaches to programmed cell death pathways.

• KR-12 Peptide Engineering: Innovations in Antimicrobial Desi

  2026-05-24

  The reviewed article details the design, engineering, and biomedical applications of KR-12, a minimal human cathelicidin-derived antimicrobial peptide. Through structural modifications and nano-formulation strategies, the study showcases enhanced efficacy against drug-resistant and biofilm-forming pathogens, with implications for targeted antimicrobial delivery and therapeutic development.

• Strategic P-gp Modulation: Zosuquidar (LY335979) in Translat

  2026-05-23

  Zosuquidar (LY335979) 3HCl, a next-generation P-glycoprotein inhibitor, offers translational researchers a robust, evidence-backed tool to address multidrug resistance (MDR) in oncology. This article integrates mechanistic insight, experimental protocol guidance, and clinical translation strategy, referencing recent advances in transporter biology and pharmacokinetics to inform best practices for MDR reversal. By articulating the unique strengths of APExBIO's Zosuquidar and bridging insights from both foundational and current literature, we chart a visionary yet actionable course for translational cancer research.

• Direct Mouse Genotyping Kit Plus: Reliable Results in Modern

  2026-05-22

  This scenario-driven guide demonstrates how the Direct Mouse Genotyping Kit Plus (SKU K1027) streamlines mouse genotyping workflows, supporting robust transgene detection, gene knockout validation, and animal colony genetic screening. With evidence-backed insights and protocol recommendations, biomedical researchers will discover how SKU K1027 enhances reproducibility and confidence in experimental outcomes.

• Pharmacokinetics of Corydalis saxicola Alkaloids in MASH Mod

  2026-05-22

  This study systematically characterizes the pharmacokinetic variability of major alkaloids from Corydalis saxicola Bunting in mouse models of metabolic dysfunction-associated steatohepatitis (MASH). The findings demonstrate how disease-induced modulation of hepatic enzymes and transporters, including P-glycoprotein (P-gp), alters systemic and tissue distribution, providing important guidance for optimizing therapeutic regimens in chronic liver disease.

• HATU (1-[Bis(dimethylamino)methylene]...) for Reliable Amide

  2026-05-21

  This article addresses common laboratory challenges in peptide synthesis chemistry, focusing on reproducibility and workflow optimization with HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate), SKU A7022. Scenario-driven insights demonstrate how APExBIO's high-purity HATU supports sensitive and efficient amide and ester formation, equipping biomedical researchers with practical, evidence-based strategies for robust experimental outcomes.

• iRGD-Modified RBC Membranes Boost PDT Efficacy in Neuroblast

  2026-05-21

  This study introduces a biomimetic nanocarrier system using iRGD-functionalized red blood cell membranes to enhance photodynamic therapy in neuroblastoma. The approach demonstrates improved drug encapsulation, tumor penetration, and systemic circulation, resulting in markedly increased therapeutic efficacy and reduced tumor growth in preclinical models.

• Triptolide (PG490): Precision Transcriptional Inhibition Red

  2026-05-20

  This article delivers a strategic, evidence-backed perspective on Triptolide (PG490) as a next-generation tool for translational researchers. Integrating mechanistic discoveries—including recent insights from allotetraploid Xenopus laevis studies—this piece explores how Triptolide enables precision inhibition of transcriptional and matrix metalloproteinase pathways, advances experimental workflows in cancer and immunology, and opens new frontiers for modulating pluripotency and cell fate. Key protocol guidance, competitive analysis, and a forward-looking outlook ensure practical impact for the research community.

• Amikacin Sulfate: Intracellular Pharmacology and Targeted Ef

  2026-05-20

  Explore the advanced pharmacodynamics of Amikacin Sulfate, focusing on its intracellular uptake, targeted drug delivery, and precision against non-tuberculous mycobacterial infections. This article delivers fresh insights for researchers optimizing aminoglycoside antibiotic strategies.

• Bradykinin B2 Receptors Regulate Peristaltic Reflex in Guine

  2026-05-19

  This study elucidates the inhibitory role of bradykinin B2 receptors in the modulation of the peristaltic reflex in guinea pig isolated ileum, employing selective agonists and antagonists to dissect receptor-specific actions. The findings refine mechanistic understanding of gastrointestinal motility and provide a rigorous framework for future pharmacological investigations targeting the bradykinin pathway.

• Gut-Brain Cholinergic Pathways Mediate B. fragilis Antiseizu

  2026-05-19

  Jia et al. reveal that Bacteroides fragilis suppresses seizures through an enhanced gut-brain cholinergic signaling axis, engaging colonic ChAT+ cells and vagal pathways. Their translational study demonstrates both preclinical and clinical efficacy, providing a mechanistic foundation for microbiota-based therapies in refractory pediatric epilepsy.

• Repurposing Novobiocin for SFTSV: In Vitro Antiviral Insight

  2026-05-18

  This study systematically evaluated 19 FDA-approved drugs, revealing that Novobiocin, an aminocoumarin antibiotic, demonstrated significant in vitro antiviral activity against severe fever with thrombocytopenia syndrome virus (SFTSV) with low cytotoxicity. These findings highlight drug repurposing as a promising avenue for developing urgently needed antivirals against emerging tick-borne pathogens.

15864 records 1/1058 page Next 12345 下5页 Last page